AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
IRINOTECAN
43 registrations across 8 African markets— 20 active
Markets with IRINOTECAN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Irinotecan HCl AqVida 20 mg/ml Concentrate for solution for infusion | 🇷🇼Rwanda | Laurus Labs Limited | active | May 2031 |
| IRITERO 40 SOLUTION | 🇿🇼Zimbabwe | HETERO LABS LTD | active | May 2030 |
| IRITERO 100 SOLUTION | 🇿🇼Zimbabwe | HETERO LABS LTD | active | May 2030 |
| IRINOTECAN HCL AQVIDA Solution à diluer pour perfusion / 40 MG/2ML | 🇹🇳Tunisia | AQVIDA GMBH | expired | Aug 2023 |
| EMCURE IRINOTECAN 100 mg/5 ml | 🇿🇦South Africa | Emcure- Pharmaceutical South Africa (Pty) Ltd | suspended | Jul 2023 |
| EMCURE IRINOTECAN 40 mg/2 ml | 🇿🇦South Africa | Emcure- Pharmaceutical South Africa (Pty) Ltd | suspended | Jul 2023 |
| IRNOCEL SOLUTION FOR INJECTION INJECTION | 🇳🇬Nigeria | L'PACE MAKER PHARMA LTD | expired | Feb 2023 |
| IRINOTECAN HOSPIRA Solution injectable pour perfusion / 20 mg/ml (40mg/2ml) | 🇹🇳Tunisia | HOSPIRA UK Limited | expired | Jun 2022 |
| IRINOTECAN KABI 40 mg Solution injectable pour perfusion / 20 mg/ml | 🇹🇳Tunisia | FRESENIUS KABI FRANCE | expired | Aug 2021 |
| IRINOTECAN KABI 100 MG Solution injectable pour perfusion / 20 mg/ml | 🇹🇳Tunisia | FRESENIUS KABI FRANCE | expired | Aug 2021 |
| CYTOTECAN Solution injectable pour perfusion / 100mg/5ml | 🇹🇳Tunisia | CYTOPHARMA | expired | Sept 2020 |
| CYTOTECAN Solution injectable pour perfusion / 300 mg/ 15 ml | 🇹🇳Tunisia | CYTOPHARMA | expired | Sept 2020 |
| CYTOTECAN Solution injectable pour perfusion / 40mg/2ml | 🇹🇳Tunisia | CYTOPHARMA | expired | Sept 2020 |
| IRINOTECAN THYMORGAN Solution injectable pour perfusion / 100 mg/ 5 ml | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Jan 2017 |
| IRINOTECAN THYMORGAN Solution injectable pour perfusion / 40 mg/ 2 ml | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Jan 2017 |
| IRINOTECAN VIATRIS Solution injectable pour perfusion / 20 mg/ml (40mg) | 🇹🇳Tunisia | VIATRIS SANTE | expired | Jul 2016 |
| IRINOTECAN VIATRIS Solution injectable pour perfusion / 20 mg/ml (100mg) | 🇹🇳Tunisia | VIATRIS SANTE | expired | Jul 2016 |
| IRINOTECAN VIATRIS Solution injectable pour perfusion / 20 mg/ml (300mg) | 🇹🇳Tunisia | VIATRIS SANTE | expired | Jul 2016 |
| IRINOTECAN KABI 100 MG Solution injectable pour perfusion / 20 mg/ml | 🇹🇳Tunisia | FRESENIUS KABI ONCOLOGY PLC | expired | May 2012 |
| IRINOTECAN KABI 40 MG Solution injectable pour perfusion / 20 mg/ml | 🇹🇳Tunisia | FRESENIUS KABI ONCOLOGY PLC | expired | May 2012 |
| IRINOTECAN EBEWE 40 MG Solution injectable pour perfusion / (20 mg/ml) | 🇹🇳Tunisia | EBEWE Pharma | expired | Apr 2012 |
| IRINOTESIN Solution injectable pour perfusion / 40 mg/2ml | 🇹🇳Tunisia | ACTAVIS SRL ROMANIA | expired | Jul 2010 |
| IRINOTESIN Solution injectable pour perfusion / 100 mg/5ml | 🇹🇳Tunisia | ACTAVIS SRL ROMANIA | expired | Jul 2010 |
| DBL IRINOTECAN Solution injectable / 100 MG/5ML | 🇹🇳Tunisia | HOSPIRA AUSTRALIA PTY | expired | Jan 2010 |
| CAMPTO Solution injectable pour perfusion / 20 mg/ml (100mg) | 🇹🇳Tunisia | PFIZER HOLDING FRANCE | expired | Dec 2009 |
| CAMPTO Solution injectable pour perfusion / 20 mg/ml (40mg) | 🇹🇳Tunisia | PFIZER HOLDING FRANCE | expired | Dec 2009 |
| CAMPTO solution injectable / 100 mg / 5 ml | 🇸🇳Senegal | AVENTIS PHARMA | active | — |
| IRNIZET 40 Solution for injection/concentrate for solution for infusion | 🇹🇿Tanzania | Eugia Pharma Specialities Limited | active | — |
| TECAN SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| IRINOTECAN COOPER SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| IRINOTECAN COOPER SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| CAMPTO SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| IRINOTECAN SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| Irinotecan Hydrochloride 20 mg/mL Concentrate for Solution for Infusion (5 mL) Solution for Infusion | 🇹🇿Tanzania | Shilpa Medicare Limited | active | — |
| IRINOCYT 100 MG/5ML SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| IRINOTECAN COOPER SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| IRINOTECAN SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| IRINOTECAN COOPER SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| IRITERO 100 Injection | 🇹🇿Tanzania | Hetero Labs Limited | active | — |
| IRNIZET 300 Solution for injection/concentrate for solution for infusion | 🇹🇿Tanzania | Eugia Pharma Specialities Limited | active | — |
| CAMPTO SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| IRINOCYT 40 MG/2ML SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| TECAN solution injectable / 100 mg / 5 ml | 🇸🇳Senegal | GENPHARMA | active | — |
IRINOTECAN in Africa — Regulatory Overview
IRINOTECAN is registered across 8 African markets with 43 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco, Tanzania, Senegal and 4 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 43 registrations, 20 (47%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.